Cargando…
Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes
BACKGROUND: Pulmonary Alveolar Proteinosis (PAP) is an uncommon pulmonary disease characterized by the accumulation of surfactant composed of proteins and lipids due to disruption of surfactant clearance by alveolar macrophages. The current standard treatment is lung lavage. There are no specific cr...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577214/ https://www.ncbi.nlm.nih.gov/pubmed/36267924 |
_version_ | 1784811709215539200 |
---|---|
author | Hassanzad, Maryam Tashayoie-Nejad, Sabereh Boloursaz, Mohammadreza Mahdaviani, Seyed Alireza Baghaie, Nooshin Ghaffaripour, Hosseinali Aghahosseini, Farahnaz Hossein Ahmadi, Zargham Parsa, Tahereh Farzanegan, Behrooz Fakharian, Atefeh Seyedi, Seyed Javad Velayati, Ali Akbar |
author_facet | Hassanzad, Maryam Tashayoie-Nejad, Sabereh Boloursaz, Mohammadreza Mahdaviani, Seyed Alireza Baghaie, Nooshin Ghaffaripour, Hosseinali Aghahosseini, Farahnaz Hossein Ahmadi, Zargham Parsa, Tahereh Farzanegan, Behrooz Fakharian, Atefeh Seyedi, Seyed Javad Velayati, Ali Akbar |
author_sort | Hassanzad, Maryam |
collection | PubMed |
description | BACKGROUND: Pulmonary Alveolar Proteinosis (PAP) is an uncommon pulmonary disease characterized by the accumulation of surfactant composed of proteins and lipids due to disruption of surfactant clearance by alveolar macrophages. The current standard treatment is lung lavage. There are no specific criteria for lavage, but in case of observing these signs it is recommended to perform lavage for the patient: progressive respiratory failure, no labored breathing at rest, and drop in oxygen level during activity (>5%). MATERIALS AND METHODS: In this study, patients with PAP admitted to Pediatric ward of Masih Daneshvari Hospital were studied. The required data were collected including the patient's demographic data, clinical signs and radiographic data, the number of admissions, the age of diagnosis, detection and treatment methods, number of lavage, current condition of the patient, and in case of death, the cause of death. RESULTS: In this study, 17 patients with PAP who were admitted during the past 15 years were examined; among which 7 patients were boys (41.2%) and 10 were girls (58.8%). The mean age of population was 11.79±7.21 years. Transbronchial Lung Biopsy (TBLB) (47.1%) and open lung biopsy (52.9%) were used for diagnosis of patients. Lung lavage was used to treat patients, 15 of whom were treated by this method. Five of the patients died because of their serious conditions. CONCLUSION: Therapy method in the present study was lavage for both lungs, and it was performed for all patients except for two patients due to their anatomical complications. This method is still considered as the gold standard for PAP. Considering the findings from previous studies and the present study, it seems that Whole Lung Lavage (WLL) was fruitful for patients who had the indication for using this therapy and it played a significant role in improving the prognosis of patients. Besides, it is recommended to do follow-up regularly in order to have more therapeutic efficacy and increased patient longevity. |
format | Online Article Text |
id | pubmed-9577214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | National Research Institute of Tuberculosis and Lung Disease |
record_format | MEDLINE/PubMed |
spelling | pubmed-95772142022-10-19 Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes Hassanzad, Maryam Tashayoie-Nejad, Sabereh Boloursaz, Mohammadreza Mahdaviani, Seyed Alireza Baghaie, Nooshin Ghaffaripour, Hosseinali Aghahosseini, Farahnaz Hossein Ahmadi, Zargham Parsa, Tahereh Farzanegan, Behrooz Fakharian, Atefeh Seyedi, Seyed Javad Velayati, Ali Akbar Tanaffos Original Article BACKGROUND: Pulmonary Alveolar Proteinosis (PAP) is an uncommon pulmonary disease characterized by the accumulation of surfactant composed of proteins and lipids due to disruption of surfactant clearance by alveolar macrophages. The current standard treatment is lung lavage. There are no specific criteria for lavage, but in case of observing these signs it is recommended to perform lavage for the patient: progressive respiratory failure, no labored breathing at rest, and drop in oxygen level during activity (>5%). MATERIALS AND METHODS: In this study, patients with PAP admitted to Pediatric ward of Masih Daneshvari Hospital were studied. The required data were collected including the patient's demographic data, clinical signs and radiographic data, the number of admissions, the age of diagnosis, detection and treatment methods, number of lavage, current condition of the patient, and in case of death, the cause of death. RESULTS: In this study, 17 patients with PAP who were admitted during the past 15 years were examined; among which 7 patients were boys (41.2%) and 10 were girls (58.8%). The mean age of population was 11.79±7.21 years. Transbronchial Lung Biopsy (TBLB) (47.1%) and open lung biopsy (52.9%) were used for diagnosis of patients. Lung lavage was used to treat patients, 15 of whom were treated by this method. Five of the patients died because of their serious conditions. CONCLUSION: Therapy method in the present study was lavage for both lungs, and it was performed for all patients except for two patients due to their anatomical complications. This method is still considered as the gold standard for PAP. Considering the findings from previous studies and the present study, it seems that Whole Lung Lavage (WLL) was fruitful for patients who had the indication for using this therapy and it played a significant role in improving the prognosis of patients. Besides, it is recommended to do follow-up regularly in order to have more therapeutic efficacy and increased patient longevity. National Research Institute of Tuberculosis and Lung Disease 2021-04 /pmc/articles/PMC9577214/ /pubmed/36267924 Text en Copyright© 2021 National Research Institute of Tuberculosis and Lung Disease https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Original Article Hassanzad, Maryam Tashayoie-Nejad, Sabereh Boloursaz, Mohammadreza Mahdaviani, Seyed Alireza Baghaie, Nooshin Ghaffaripour, Hosseinali Aghahosseini, Farahnaz Hossein Ahmadi, Zargham Parsa, Tahereh Farzanegan, Behrooz Fakharian, Atefeh Seyedi, Seyed Javad Velayati, Ali Akbar Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes |
title | Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes |
title_full | Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes |
title_fullStr | Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes |
title_full_unstemmed | Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes |
title_short | Pulmonary Alveolar Proteinosis in Children: Diagnosis and Treatment Outcomes |
title_sort | pulmonary alveolar proteinosis in children: diagnosis and treatment outcomes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577214/ https://www.ncbi.nlm.nih.gov/pubmed/36267924 |
work_keys_str_mv | AT hassanzadmaryam pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT tashayoienejadsabereh pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT boloursazmohammadreza pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT mahdavianiseyedalireza pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT baghaienooshin pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT ghaffaripourhosseinali pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT aghahosseinifarahnaz pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT hosseinahmadizargham pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT parsatahereh pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT farzaneganbehrooz pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT fakharianatefeh pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT seyediseyedjavad pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes AT velayatialiakbar pulmonaryalveolarproteinosisinchildrendiagnosisandtreatmentoutcomes |